01 Stock Market
As of Oct 12, U.S. stock index futures performed as follows: Dow Jones futures rose 0.10% to 51,978.00, S&P 500 futures rose 0.05% to 7,863.75, and Nasdaq 100 futures fell 0.18% to 31,054.00. The setup points to a cautious but resilient tone, with the Dow and S&P slightly firmer while the Nasdaq 100 lagged on pressure in parts of the semiconductor complex. Major index data also showed the Dow Jones up 0.83%, the Nasdaq up 0.64%, and the S&P 500 up 0.59%, offering a positive broader backdrop even as futures signaled some giveback.
Notable Stock Movers: Among large-cap names with clear pre-market data, Salesforce up 4% at $238.28 after BofA double-upgraded the stock and lifted its price objective, while Apple up 0.31% at $337.67. In semiconductors, NVIDIA down 0.20% at $228.81, Advanced Micro Devices down 1.09% at $601.50, Intel down 1.61% at $103.02, and Micron Technology fell 2.46% at $1,003.70; Marvell Technology fell 1.55% at $271.00 and Broadcom fell 0.70% at $359.02. Elsewhere, Meta Platforms up 1.64% at $730.44, Tesla up 0.03% at $382.82, and Amazon fell 0.19% at $261.93. The move set also included IREN up 3.89% at $36.56.
Pre-market breadth was uneven, with gains concentrated in a handful of software and select internet names while chip-equipment and memory stocks softened. Taiwan Semiconductor Manufacturing was slightly higher at $453.82, but the broader chip group remained under pressure, including Western Digital down 1.59% at $390.97 and Seagate Technology down 1.85% at $768.50.
02 Other Markets
• 10-year U.S. Treasury yield fell 0.04%, to 5.24%.
• U.S. Dollar Index rose 0.1761% to 102.41.
• WTI crude oil futures rose 1.47% to 93.20 USD/barrel; COMEX gold futures fell 0.55% to 4193.30 USD/ounce.
03 Key News
1. Salesforce received a BofA double upgrade that lifted its price target and helped drive pre-market gains. BofA Global Research upgraded the software company to buy from underperform and raised its price objective to $285 from $160. The firm said concerns about AI-driven disintermediation were easing because large enterprises are unlikely to replace platforms that store business logic, data, workflows, and compliance frameworks. The note suggested AI could deepen customer dependence on Salesforce’s platform rather than weaken it.
2. Insulet launched its Omnipod Discover platform across the U.S. to expand diabetes data access for users and clinicians. The company said the platform provides personalized insights, including glucose and insulin delivery reports, for Omnipod 5 users. Insulet said the product is already being used by more than 15,000 users and over 1,800 healthcare professionals in a limited market release. The rollout broadens the company’s connected-care offering in diabetes management.
3. Qingdao Gon Technology agreed to acquire an 80% stake in Sichuan Zhongfuneng New Material Technology. The deal value was set at RMB1.50 billion. The transaction expands Qingdao Gon Technology’s footprint in new materials and could strengthen its supply-chain and product capabilities. The agreement is one of the notable corporate actions reported in the pre-bell window.
4. ANI Pharmaceuticals said a phase 4 Iluvien study met its primary endpoints in chronic NIU-PS. The company reported statistically significant results in the intent-to-treat group at six months, with efficacy sustained through 24 months. ANI said patients gained vision-test letters and experienced a meaningful reduction in retinal thickness. The company also said most adverse events were consistent with prior studies of the implant.
5. Pepco launched a competitive bidding process for Washington, D.C. standard-offer power supply contracts. The Exelon unit said the tender is intended to secure reliable electricity supply at market-based prices for retail customers. Pepco said retail rates are expected to be posted later and the resulting supply contracts would begin in a future service period. The move affects a regulated utility customer base rather than a discretionary consumer segment.
6. Dot AI completed a $65 million all-stock acquisition of Envoy Technologies. The company said the transaction closed as an all-stock deal, formalizing Envoy Technologies as part of its broader corporate structure. The acquisition adds assets and operating scale without a cash outlay, which may matter for future integration and balance-sheet flexibility. No further operational guidance was disclosed in the item reviewed.
7. Yuanjie Semiconductor Technology reported a sharp increase in quarterly net profit. Reuters said the company’s net profit rose 578.9% to 659.7% year over year. The update points to a significant earnings inflection, although the brief did not provide additional operating details in the content reviewed. The report is clearly event-driven and relevant to semiconductor-related trading interest.
8. Macy’s had its outlook revised to positive by S&P on operational improvements. S&P affirmed the retailer’s ratings while changing the outlook. The action reflected better operational performance rather than a new financing event or corporate transaction. It is a credit-focused update with possible implications for the company’s funding profile.
9. Meta won a Nobel-linked boost to its policy backdrop as two U.S. economists received the Nobel Prize for Economic Sciences. The award recognized research on household and business expectations and economic stability. The announcement matters for macro-policy discussions because the work emphasized the importance of clear communication by governments and central banks. The item is institutional and concrete, though not company-specific.
10. Other analyst actions added to the day’s stock-specific flow, including O-I Glass and Shattuck Labs. Truist cut its price target on O-I Glass while keeping a buy rating, and UBS initiated Shattuck Labs at buy with a $17 target. These are discrete coverage actions rather than broad market commentary, and they can influence near-term trading in the affected names. They were part of a busy pre-open pipeline of rating changes.
Sources: Reuters, Dow Jones, Tiger Newspress, public market data
Disclaimer: For informational purposes only; not investment advice.
Comments